Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Iterum Therapeutics plc - Ordinary Share (NQ:ITRM)

0.3645 -0.0055 (-1.49%)
Streaming Delayed Price Updated: 2:14 PM EST, Dec 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Iterum Therapeutics plc - Ordinary Share

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Iterum Therapeutics (ITRM) Earnings Transcript ↗
Iterum Therapeutics (ITRM) Earnings Transcript 
Via The Motley Fool
Topics Intellectual Property
News headline image
Iterum Therapeutics PLC (NASDAQ:ITRM) Stock Plummets on Wider-Than-Expected Q3 Loss ↗
Iterum Therapeutics stock plunges after Q3 2025 earnings miss estimates, with a wider-than-expected loss overshadowing its new product launch. 
Via Chartmill
Topics Earnings
News headline image
A Glimpse of Iterum Therapeutics's Earnings Potential ↗
 
Via Benzinga
News headline image
Top Stocks With Earnings This Week: Plug, Oklo, Circle And More ↗
Here's a look at this week's earnings reports that are most likely to be watched by retail investors, including Oklo, Plug and Circle. 
Via Benzinga
News headline image
Earnings Scheduled For November 14, 2025 ↗
 
Via Benzinga
News headline image
ITRM Reports Results ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Iterum Therapeutics PLC (NASDAQ:ITRM) Reports Wider Q2 2025 Loss, Market Optimistic Ahead of ORLYNVAH Launch ↗
Iterum Therapeutics PLC reports Q2 2025 earnings with a wider loss than expected, but stock rises 4.15% pre-market as investors anticipate ORLYNVAH's August 2025 launch. Cash reserves extend into... 
Via Chartmill
News headline image
Earnings Scheduled For August 5, 2025 ↗
 
Via Benzinga
News headline image
Insights Ahead: Iterum Therapeutics's Quarterly Earnings ↗
 
Via Benzinga
News headline image
A Look Ahead: Iterum Therapeutics's Earnings Forecast ↗
 
Via Benzinga
News headline image
Which stocks are moving after the closing bell on Monday? ↗
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Top movers in Tuesday's pre-market session ↗
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements. 
Via Chartmill
News headline image
A Look at Iterum Therapeutics's Upcoming Earnings Report ↗
 
Via Benzinga
News headline image
Iterum Therapeutics's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 13, 2025 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Wall Street Drops On Tariffs Threat, Dollar Rises, Uber Rockets On Ackman's Tweet: What's Driving Markets Friday? ↗
Wall Street slumped into negative territory late in the week as renewed fears over inflation and trade tariffs eroded risk appetite. 
Via Benzinga
Topics Economy World Trade
News headline image
Earnings Scheduled For February 7, 2025 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
FDA Approval Of Orlynvah For Urinary Tract Infections Marks Milestone For Iterum, Paves Way For New Strategic Partnerships ↗
Iterum Therapeutics' Orlynvah receives FDA approval for treating uncomplicated UTIs in adult women, marking its first approved indication and a U.S. first for oral penems. 
Via Benzinga
News headline image
Earnings Scheduled For November 14, 2024 ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q2 2024 ↗
ITRM stock results show that Iterum Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q1 2024 ↗
ITRM stock results show that Iterum Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
It's time to start the trading week with a dive into the biggest pre-market stock movers worth watching on Monday morning! 
Via InvestorPlace
News headline image
ITRM Stock Earnings: Iterum Therapeutics Beats EPS for Q4 2023 ↗
ITRM stock results show that Iterum Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Earnings Scheduled For March 28, 2024 ↗
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.